Factors associated with acute gout attacks in normouricaemic gout patients receiving allopurinol: a retrospective study

References

• Underwood M. Diagnosis and management of gout. BMJ 2006;332:1315–19.
   PubMed Web of Science ®Google Scholar
• Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricaemia. Risks and consequences in the Normative Aging Study. Am J Med 1987;82:421–6.
   Google Scholar
• Shoji A, Yamanaka H, Kamatani N. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum 2004;51:321–5.
   PubMed Web of Science ®Google Scholar
• McCarty DJ. Gout without hyperuricemia. J Am Med Assoc 1994;271:302–3.
   PubMed Web of Science ®Google Scholar
• Schlesinger N, Baker DG, Schumacher HR Jr. Serum urate during bouts of acute gouty arthritis. J Rheumatol 1997;24:2265–6.
   PubMed Web of Science ®Google Scholar
• Urano W, Yamanaka H, Tsutani H, Nakajima H, Matsuda Y, Taniguchi A, . The inflammatory process in the mechanism of decreased serum uric acid concentrations during acute gouty arthritis. J Rheumatol 2002;29:1950–3.
   PubMed Web of Science ®Google Scholar
• Hutton I, Gamble G, Gow P, Dalbeth N. Factors associated with recurrent hospital admissions for gout: a case-control study. J Clin Rheumatol 2009;15:271–4.
   PubMed Web of Science ®Google Scholar
• Neogi T, Hunter DJ, Chaisson CE, Allensworth-Davies D, Zhang Y. Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study. J Rheumatol 2006;33:104–9.
   PubMed Web of Science ®Google Scholar
• Choi HK, Atkinson K, Karlson EW, Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 2005;165:742–8.
   PubMed Web of Science ®Google Scholar
• Roubenoff R, Klag MJ, Mead LA, Liang KY, Seidler AJ, Hochberg MC. Incidence and risk factors for gout in white men. J Am Med Assoc 1991;266:3004–7.
   PubMed Web of Science ®Google Scholar
• Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004;363:1277–81.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Woods R, Chaisson CE, Neogi T, Niu J, McAlindon TE, . Alcohol consumption as a trigger of recurrent gout attacks. Am J Med 2006;119:800.e13–18.
   Google Scholar
• Hunter DJ, York M, Chaisson CE, Woods R, Niu J, Zhang Y. Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study. J Rheumatol 2006;33: 1341–5.
   PubMed Web of Science ®Google Scholar
• Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20:895–900.
   PubMed Web of Science ®Google Scholar
• Hande KR, Noone RM, Stone WJ. Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency. Am J Med 1984;76:47–56.
   Google Scholar
• Saag KG, Choi H. Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Res Ther 2006;8(Suppl 1):S2.
   PubMed Web of Science ®Google Scholar
• Borstad GC, Bryant LR, Abel MP, Scroggie DA, Harris MD, Alloway JA. Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis. J Rheumatol 2004;31:2429–32.
   PubMed Web of Science ®Google Scholar
• Perez-Ruiz F, Calabozo M, Pijoan JI, Herrero-Beites AM, Ruibal A. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum 2002;47:356–60.
   PubMed Web of Science ®Google Scholar
• Scott JT, Holloway VP, Glass HI, Arnot RN. Studies of uric acid pool size and turnover rate. Ann Rheum Dis 1969;28:366–73.
   PubMed Web of Science ®Google Scholar
• Simkin PA. Isolation and quantification of serum uric acid by adsorption chromatography. Clin Chem 1970;16:191–4.
   PubMed Web of Science ®Google Scholar
• Simkin PA. Uric acid metabolism in Cebus monkeys. Am J Physiol 1971;221:1105–9.
   PubMedGoogle Scholar
• Bianchi R, Vitali C, Clerico A, Pilo A, Riente L, Fusani L, . Uric acid metabolism in normal subjects and in gouty patients by chromatographic measurement of 14C-uric acid in plasma and urine. Metabolism 1979;28:1105–13.
   PubMed Web of Science ®Google Scholar
• Jordan KM, Cameron JS, Snaith M, Zhang W, Doherty M, Seckl J, . British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology (Oxford) 2007;46:1372–4.
   PubMed Web of Science ®Google Scholar
• Li-Yu J, Clayburne G, Sieck M, Beutler A, Rull M, Eisner E, . Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout? J Rheumatol 2001;28:577–80.
   Google Scholar
• Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Eustace D, Palo WA, . Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 2005;353:2450–61.
   PubMed Web of Science ®Google Scholar
• Perez-Ruiz F, Calabozo M, Fernandez-Lopez MJ, Herrero-Beites A, Ruiz-Lucea E, Garcia-Erauskin G, . Treatment of chronic gout in patients with renal function impairment: an open, randomized, actively controlled study. J Clin Rheumatol 1999;5:49–55.
   PubMed Web of Science ®Google Scholar
• Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, . EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006;65:1312–24.
   Google Scholar
• Wu EQ, Patel PA, Mody RR, Yu AP, Cahill KE, Tang J, . Frequency, risk, and cost of gout-related episodes among the elderly: does serum uric acid level matter? J Rheumatol 2009;36:1032–40.
   PubMed Web of Science ®Google Scholar